![David C. Rees](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David C.
Rees worked as Director & Head-Medicinal Chemistry at AstraZeneca PLC, Principal at Harvard University, N.V.
Organon, and Parke-Davis & Co. Ltd., Vice President-Medicinal Chemistry at Astex Therapeutics Ltd. from 2003 to 2009, and Senior Vice President-Medicinal Chemistry at Astex Pharmaceuticals, Inc.
| Unternehmen | Position | Ende |
|---|---|---|
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Corporate Officer/Principal | - |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Direktor/Vorstandsmitglied | - |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Corporate Officer/Principal | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
